BrightInsight

Covid-19’s digital imperative for biopharma and medtech [Sponsored]

by Nile
October 21, 2020

The disruption to biopharma and medtech businesses caused by Covid-19, such as product launch and clinical trial delays, has underscored the need for a more digital focused strategy.

Startups talk about what it’s like to raise money in a pandemic

by Nile
July 23, 2020

MedCity spoke with Evidation and BrightInsight, two startups that have recently announced funding rounds, amid a Covid-19 pandemic worsening in the U.S.